Euroapi S.A. (EAPIF) Research

Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications.

Market snapshot

Symbol
EAPIF
Price
$1.51
Day change
0.00%
Market cap
$120.8M
P/E ratio
-0.57x
52-week range
1.27-3.741
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 1 month

Peer companies

  • Clinuvel Pharmaceuticals Limited (CLVLF)
  • Cellectis S.A. (CMVLF)
  • CytoDyn Inc. (CYDY)
  • 3-D Matrix, Ltd. (DMTRF)
  • Ion Beam Applications S.A. (IOBCF)
  • Kneat.com, Inc. (KSIOF)
  • Lattice Biologics Ltd. (LBLTF)
  • Northwest Biotherapeutics, Inc. (NWBO)

Open Euroapi S.A. (EAPIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.